Fischer Medical Ventures Receives Upgraded Stock Call from MarketsMOJO, Showing Positive Results and Bullish Trend

Fischer Medical Ventures, a smallcap company in the chemicals industry, has recently received an upgraded stock call from MarketsMOJO. The stock has been upgraded to 'Hold' on October 8, 2024.
The upgrade is based on the company's positive results in June 2024, with a PAT(Q) of Rs 0.84 crore, the highest in recent times. The stock is currently in a bullish range and the technical trend has improved from mildly bullish on October 8, 2024. Multiple factors such as MACD, Bollinger Band, KST, and OBV are also indicating a bullish trend for the stock.

In terms of performance, Fischer Medical Ventures has been outperforming the BSE 500 index in the long term as well as the near term. In the last 1 year, the stock has generated a return of 792.49%, showcasing its market-beating performance.

However, the company's long term fundamental strength is weak with operating losses and poor growth in net sales and operating profit over the last 5 years. Additionally, the company has a high debt-to-equity ratio of 0 times, indicating a high level of debt.

The stock also has a very expensive valuation with a price-to-book value of 43.4 and a ROE of 2.3. Despite the high returns generated by the stock in the past year, its profits have fallen by 0%.

It is worth noting that despite being a smallcap company, domestic mutual funds hold only 0% of the company's shares. This could signify that either they are not comfortable with the current price or they have not conducted in-depth research on the company.